Peptide Vault Labs
≥99% Purity
Made in the USA
Research Use Only
Third-Party Batch Tested
Research Library
Growth Hormone SignalingTesamorelin research vial

Peptide Vault Labs Education

Tesamorelin

Also known as TH9507, GHRH Analog

Primary research target

Stabilized GHRH analog with established clinical and regulatory literature involving growth-hormone-axis pharmacology.

Research category

Growth Hormone Signaling

GHRH analogs, ghrelin-receptor agonists, secretagogues, and related endocrine research materials.

Educational research information only

This profile describes areas of scientific interest. It does not provide medical advice, dosing, reconstitution, administration, treatment, or human-use instructions.

Browse research catalog

Compound

Tesamorelin

Research category

Growth Hormone Signaling

Information type

Educational overview

Common names and aliases

TH9507GHRH Analog

Catalog references

  • Tesamorelin

Related research

Explore similar compounds

View full library

CJC-1295 No DAC

GHRH-receptor agonist research focused on pulsatile growth-hormone signaling and endocrine pharmacology.

View profile
Ipamorelin research vial

Ipamorelin

Selective ghrelin-receptor agonist investigated in growth-hormone secretion and endocrine signaling research.

View profile
Hexarelin research vial

Hexarelin

Potent ghrelin-receptor agonist investigated in growth-hormone secretion and cardiovascular and endocrine models.

View profile
IGF-1 LR3 research vial

IGF-1 LR3

Modified IGF-1 analog investigated in receptor signaling, cell growth, protein synthesis, and prolonged IGF-binding-protein resistance.

View profile

Educational and laboratory research information only

The Peptide Vault Labs Research Library is provided solely for educational, analytical, and laboratory research reference. Content does not diagnose, treat, cure, or prevent disease and must not be interpreted as prescribing, dosing, administration, reconstitution-for-use, or patient-care guidance. Experimental findings—especially animal, cell, and in vitro findings—do not establish safety or efficacy in humans. Researchers must use validated institutional protocols, applicable laws, safety data sheets, certificates of analysis, and qualified laboratory oversight.